BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Business

  TearLab Corporation To Release Q1 2014 Financial Results On May 8, 2014

  April 17, 2014

   · 

  1 min read
• Drug Development

  Agios Pharmaceuticals Initiates Phase 1 Study Of AG-348, A First-in-class PKR Activator, For Pyruvate Kinase Deficiency

  April 17, 2014

   · 

  1 min read
• Biotech Bay

  Relypsa, Inc. Announces Closing Of Public Offering Of Common Stock

  April 17, 2014

   · 

  1 min read
• Business

  Theorem Clinical Research Expands Partnership With Medidata Solutions, Inc.

  April 17, 2014

   · 

  1 min read
• Business

  Alphatec Spine To Release First Quarter 2014 Financial Results

  April 17, 2014

   · 

  1 min read
• Business

  Targeted Medical Pharma Completes Middle East Distribution Agreement

  April 17, 2014

   · 

  1 min read
• Business

  Nanosphere, Inc. To Release First Quarter Results And Host Investor Conference Call On Wednesday, May 7, 2014

  April 17, 2014

   · 

  1 min read
• Policy

  Teva Pharmaceutical Industries Limited Settles Patent Litigation With Pfizer Inc. On Celebrex®

  April 17, 2014

   · 

  1 min read
• Drug Development

  Nuvilex Could Obtain FDA Accelerated Approval After Phase 2b Clinical Trial

  April 17, 2014

   · 

  4 min read
• Pharm Country

  Antares Pharma, Inc. Release: Drug-Exposure Limitations Of Oral Methotrexate At Doses Greater Than Or Equal To 15 Mg May Be Overcome With Subcutaneous Administration

  April 17, 2014

   · 

  1 min read